Abstract:Background Major depressive disorder (MDD) is a prevalent mental health condition with significant societal impact. Owing to the intricate biological diversity of MDD, treatment efficacy remains limited. Immune biomarkers have emerged as potential predictors of treatment response, underscoring the interaction between the immune system and the brain. This study investigated the relationship between cytokine levels and cortical thickness in patients with MDD, focusing on the corticolimbic circuit, to elucidate the influence of neuroinflammation on structural brain changes and contribute to a deeper understanding of the pathophysiology of MDD. Method A total of 114 patients with MDD and 101 healthy controls (HC) matched for age, sex, and body mass index (BMI) were recruited. All participants were assessed for depression severity using the Hamilton Depression Rating Scale (HDRS), and 3.0 T T1 weighted brain MRI data were acquired. Additionally, cytokine levels were measured using a highly sensitive bead-based multiplex immunosorbent assay. Results Patients diagnosed with MDD exhibited notably elevated levels of interleukin-6 ( p = 0.005) and interleukin-8 ( p = 0.005), alongside significant cortical thinning in the left anterior cingulate gyrus and left superior frontal gyrus, with these findings maintaining significance even after applying Bonferroni correction. Furthermore, increased interleukin-6 and interleukin-8 levels in patients with MDD are associated with alterations in the left frontomarginal gyrus and right anterior cingulate cortex (ACC). Conclusions This suggests a potential influence of neuroinflammation on right ACC function in MDD patients, warranting longitudinal research to explore interleukin-6 and interleukin-8 mediated neurotoxicity in MDD vulnerability and brain morphology changes.

Affective Immunology: The Crosstalk Between Microglia and Astrocytes Plays Key Role?

The mediation of immune activation on serotonin and glutamate systems in pathological process of depression

An astroglial basis of major depressive disorder: Molecular, Cellular, and Circuit Features

Microglia Sing the Prelude of Neuroinflammation-Associated Depression

Stress induced microglial activation contributes to depression

Novel insight into astrocyte-mediated gliotransmission modulates the synaptic plasticity in major depressive disorder

Microglia in depression: current perspectives

Brain-immune crosstalk in the treatment of major depressive disorder

Targeting the CCL2-CCR2 axis in depressive disorders

Research progress of microglia and peripheral monocytes in mood disorders

Prefrontal cortex astrocytes in major depressive disorder: exploring pathogenic mechanisms and potential therapeutic targets

Major Depression: An Immune-Inflammatory Disorder

Common Cellular and Molecular Mechanisms and Interactions Between Microglial Activation and Aberrant Neuroplasticity in Depression

Astroglial Connexin 43-Mediated Gap Junctions and Hemichannels: Potential Antidepressant Mechanisms and the Link to Neuroinflammation

Inflammatory Signatures of Microglia in Hypercortisolemia-Related Depression

Unveiling the hidden pathways: Exploring astrocytes as a key target for depression therapy

The effect of inflammation markers on cortical thinning in major depressive disorder: A possible mediator of depression and cortical changes

Noteworthy perspectives on microglia in neuropsychiatric disorders

Immunotherapy for depression: Recent insights and future targets

Glycolytic metabolism: Food for immune cells, fuel for depression?

Neuroimmune Crosstalk Through Brain-Derived Neurotrophic Factor and Its Precursor Pro-Bdnf: New Insights into Mood Disorders